Dividends & Buybacks ·
Haleon plc purchased a total of 10,995,213 ordinary shares for cancellation under its share buyback programme…
HLNHaleon plc
Haleon plc purchased a total of 10,995,213 ordinary shares for cancellation under its share buyback programme announced on 12 March 2026. Purchases occurred on August 11, 12, and 13, 2026, across multiple trading venues including the London Stock Exchange, CBOE (UK), Aquis, BXE, and CXE. Prices ranged from a low of 355.80 pence to a high of 367.00 pence per share. Following settlement, registered share capital stands at 8,809,911,209 shares, with 11,807,443 held as treasury shares and 8,798,103,766 carrying voting rights. Haleon plc operates in the consumer healthcare industry, manufacturing and selling over-the-counter medicines and health supplements under brands such as Advil, Panadol, and Sensodyne.